Cite Filings / NKTR / 0001959173-25-005342

Feed Companies Filings Check

Sign in

144

Sale of Securities

NEKTAR THERAPEUTICS Filed 2025-08-19 Acc 0001959173-25-005342

Documents 1

144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

2025-08-21 4 Chief R&D Officer sold 725 shares at $26.59 ($19,278)
2025-08-21 4 Chief Legal Officer sold 676 shares at $26.59 ($17,975)
2025-08-21 4 President & CEO sold 1,573 shares at $26.59 ($41,826)
2025-08-19 144 Sale of Securities
2025-08-19 144 Sale of Securities
2025-08-19 144 Sale of Securities
2025-08-14 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…